文献速递肝病

加速度计测量的身体活动量、强度及静息-活动节律与MASLD患者全因及病因特异性死亡风险的关联

Association Between Volume, Intensity and Rhythm of Physical Activity Measured by Accelerometer and Risk of All-Cause and Cause-Specific Mortality in Individuals With MASLD.
PubMed 文献 · Aliment Pharmacol Ther · 2025-04-25

基于英国生物银行10143例MASLD患者,用加速度计测量身体活动量、强度及静息-活动节律,Cox模型分析其与全因、心血管病及癌症死亡风险的关系。较高的低强度活动、中高强度活动及正常静息-活动节律与全因和心血管病死亡风险降低相关(HR 0.712-0.805),中高强度活动和节律振幅是相对重要的贡献因素。

要点

  • 较高的低强度活动、中高强度活动及正常节律振幅和均值与MASLD患者全因及心血管病死亡风险降低相关,HR为0.712-0.805。
  • 在超过两种代谢异常亚型(超重/肥胖-血压升高-高脂血症及全部四种异常)中,全因死亡风险降低尤其明显。
  • 中高强度活动和节律振幅是MASLD患者全因及心血管病死亡风险相对重要的贡献因素。

核心结论

  • 在MASLD患者中,较高的身体活动量和强度以及正常的静息-活动节律与较低的全因和心血管病死亡风险相关,为管理指南提供了启示。

研究设计与样本

  • 研究纳入英国生物银行10143例MASLD患者,从加速度计数据计算身体活动量、强度(低强度活动、中高强度活动、久坐时间)和静息-活动节律(振幅、均值、伪F统计量、峰值时间),采用Cox比例风险模型估计其与全因、心血管病及癌症死亡风险的关系,并进一步在常见心脏代谢异常亚型中分析,同时估计人群归因风险和身体活动的相对重要性。

主要发现

  • 较高的低强度活动、中高强度活动及正常静息-活动节律(振幅和均值)与MASLD患者全因和心血管病死亡风险降低相关(HR为0.712-0.805),在超过两种代谢异常亚型(超重/肥胖-血压升高-高脂血症及全部四种异常)中全因死亡风险降低尤其明显。
  • 中高强度活动和节律振幅是MASLD患者全因和心血管病死亡风险相对重要的贡献因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) have a higher mortality risk, and physical activity is important to MASLD management. However, a comprehensive exploration of associations of volume and intensity of physical activity and rest-activity rhythm (RAR) based on an accelerometer with all-cause and cause-specific mortality in MASLD individuals was scarce. METHODS: We included 10,143 individuals with MASLD from the UK Biobank. Volume and intensity of physical activity [low-intensity physical activity (LPA), moderate-to-vigorous-intensity physical activity (MVPA) and sedentary time] and RAR (amplitude, mesor, pseudo-F statistics and acrophase) were computed from accelerometer data. The Cox proportional hazards model was used to estimate the relationships of volume and intensity of physical activity and RAR with all-cause, cardiovascular disease (CVD) and cancer mortality risk in individuals with MASLD and further in common subtypes of cardiometabolic abnormalities. The population attributable risk and relative importance of physical activity were estimated. RESULTS: Higher LPA, MVPA and normal RAR (amplitude and mesor) were associated with decreased risk of all-cause and CVD mortality among individuals with MASLD (HRs: 0.712-0.805), especially of all-cause mortality in those with common subtypes of more than two metabolic abnormalities (overweight/obesity-elevated blood pressure-hyperlipidemia and all the four abnormalities). Furthermore, we found MVPA and amplitude represented relatively important contributors to all-cause and CVD mortality risk in individuals with MASLD. CONCLUSIONS: In individuals with MASLD, a higher volume and intensity of physical activity, as well as normal RAR supported lower all-cause and CVD mortality risk, which provided insights for management guidelines.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Peng Y, Liu F, Wang P, et al. Association Between Volume, Intensity and Rhythm of Physical Activity Measured by Accelerometer and Risk of All-Cause and Cause-Specific Mortality in Individuals With MASLD. Aliment Pharmacol Ther. 2025. PMID: 40276877. doi:10.1111/apt.70169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。